Gene linked to survival after anthracyclines, anti-HER2 therapies for breast cancer - Healio

Genetic variants of the UACA gene, a critical regulator of tumor suppressor Par-4, appeared associated with OS among patients who received anthracyclines and HER2-targeted therapy, according to a study published in NPJ Breast Cancer. “Hundreds of geneti…

Genetic variants of the UACA gene, a critical regulator of tumor suppressor Par-4, appeared associated with OS among patients who received anthracyclines and HER2-targeted therapy, according to a stu… [+2729 chars]

full article...